Global spending on R&D is expected to increase 3.6% in 2011 to nearly $1.2 trillion, according to Battelle Memorial Institute and R&D Magazine’s joint analysis. It is estimated that the Americas, Asia and Europe will account for 38%, 35% and 23% of R&D spending, respectively. R&D Magazine’s 2011 Global Research Study surveyed 378 predominantly private […]

The National Institute of Health’s (NIH) Scientific Management Review Board (SMRB) has voted 12–1 to create a new translational medicine center that would combine several programs to try to get drugs to the market faster. The center would be the base for the $500 million Clinical and Translational Science Awards (CTSAs) program. This may jeopardize […]

A Tufts Center for the Study of Drug Development report indicates that pharmaceutical companies are increasingly using personalized medicine to develop drugs. According to Christopher-Paul Milne, associate director at the center, 12%–50% of drugs in development rely on a personalized medicine approach, which often involves tests to indicate which patients are most likely to experience […]

US biotechnology sales growth slowed 3% to $48.2 billion in 2009. The slowdown was the result of safety concerns, hiatuses in manufacturing, and market saturation and crowding. Though several promising products are being introduced, the forecast for 2010 is similar, with new challenges emerging: pricing, competition, US healthcare reform, patent expirations and follow-on molecules. With […]

The American Association for Laboratory Accreditation (A2LA) now offers accreditation for forensic examination laboratories, following the publication of the National Research Council’s report, “Strengthening Forensic Science in the United States: A Path Forward.” The program covers forensic examination, including DNA, fingerprints and crime scene examination, as well as forensic engineering, failure analysis and accident analysis. […]